1+ day, 15+ hour ago   (1328+ words) CRISPR Medicine News CMN Weekly (24 Juli 2026) - Your Weekly CRISPR Medicine News Some of the best links we picked up around the internet - CRISPR-Cas9 kilobase-scale nickase-targeting (KNIT) editing couples a nickase to donor-DNA recruitment, enabling programmable 0.7 to 10 kb insertions without double-strand…...

3+ day, 16+ hour ago   (335+ words) A new artificial intelligence–guided strategy can design highly divergent yet functional variants of TnpB, a compact RNA-guided nuclease that is evolutionarily related to CRISPR-Cas12 enzymes. By combining a structure-based inverse protein-folding model with evolutionary constraints, they generated synthetic nucleases…...

1+ week, 3+ day ago   (221+ words) Crop Research Uncovers a Cancer-Killing CRISPR CRISPR Medicine News Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness. - player.restream.io 1 sessionIdPreserves the visitor's session state across page requests. Maximum Storage…...

2+ week, 2+ day ago   (544+ words) , a New CRISPR Technology Platform for Cancer Therapy CRISPR Medicine News Confluence Genetics Launches Cas-CLEAR™, a New CRISPR Technology Platform for Cancer Therapy Cas12a2-based approach designed to eliminate cancer cells carrying defined genetic signatures while sparing healthy cells Lead programs…...

2+ week, 3+ day ago   (225+ words) The Series C was led by Fidelity Management & Research Company, with participation from all existing investors. The current extension includes additional participation from Lightchain Capital and BioGenerator, as well as new investors, including Blood Cancer United’s Therapy Acceleration Program® (TAP)…...

3+ week, 1+ day ago   (185+ words) The WNT–β-catenin pathway is one of the best-established drivers of colorectal cancer. More than 80% of colorectal tumours carry truncating mutations in APC, which disable the β-catenin destruction complex, allowing β-catenin to accumulate and activate oncogenic transcription. Despite decades of…...

3+ week, 2+ day ago   (687+ words) - First and only approved genetic therapy to treat children as young as 2 years for both severe sickle cell disease and transfusion-dependent beta thalassemia - - Approximately 5,500 additional children in the U.S. are now eligible for this established one-time therapy, expanding upon the prior…...

3+ week, 5+ day ago   (209+ words) First published data evaluating gene-editing treatment in children ages 5-11 with inherited blood disorders highlights the potential for earlier intervention before cumulative injury Sickle cell disease and beta thalassemia are inherited blood disorders that can cause serious, lifelong complications beginning in…...

3+ week, 5+ day ago   (326+ words) CRISPR Improves ex vivo Donor Organ Treatment CRISPR Medicine News CRISPR Improves ex vivo Donor Organ Treatment A perspective article in Nature Reviews Bioengineering outlines how CRISPR-based RNA silencing could be integrated into ex vivo machine perfusion of donor organs…...

1+ mon, 6+ day ago   (1021+ words) News: CARBON Newsletter (19 June 2026) - Your Latest News About CRISPR in AgroBio CRISPR Medicine News CARBON Newsletter (19 June 2026) - Your Latest News About CRISPR in AgroBio Some of the best links we picked up around the internet CRISPR AgroBio News (CARBON) - an…...